| Factor Information | |
|---|---|
| Data ID | 857 |
| Factor | SAVV replacement (Mechanical, Bioprosthetic) |
| Description | Adults with congenital heart disease (ACHD) undergoing systemic atrioventricular valve (SAVV) surgery are a complex, understudied population |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | We assessed midterm outcomes and prognostic factors in ACHD undergoing SAVV surgery |
| p Value | 0.001 |
| Conclusion | The rate of SAVV replacement was higher for patients with ccTGA (86%) compared to patients with AVSD and congenital MS/MR. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 486 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | AVSD/ccTGA/MS, MR |
| Reference | |
|---|---|
| PMID | 28520541 |
| Year | 2017 |
| Title | Outcomes and Prognostic Factors for Adult Patients With Congenital Heart Disease Undergoing Primary or Reoperative Systemic Atrioventricular Valve Surgery. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | retrospective cohort study | |
| Region | New York, USA | |
| Method | retrospective evaluation | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | SAVV surgery | |
| Group | ccTGA(Treatment) | Congenital MS/MR(Control) |
| Number | 12(total:14) | 5(total:14) |
| Age | 39.1 ± 15.4 years | 36.7 ± 11.4 years |
| Gender (Male: Female) | 7:7 (total) | 8:6 (total) |
| Marker Level | 0.86 | 0.36 |
